These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
739 related items for PubMed ID: 33377903
1. Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial. Zhang J, Zhao Y, Dai Y, Dang L, Ma L, Yang C, Li Y, Kong L, Wei L, Zhang S, Liu J, Xi M, Chen L, Duan X, Xiao Q, Abulizi G, Zhang G, Hong Y, Gao X, Zhou Q, Xie X, Li L, Niyazi M, Zhang Z, Tuo J, Ding Y, Si M, Chen F, Song L, Qiao Y, Lang J. JAMA Oncol; 2021 Feb 01; 7(2):263-270. PubMed ID: 33377903 [Abstract] [Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J. Health Technol Assess; 2014 Apr 01; 18(23):1-196. PubMed ID: 24762804 [Abstract] [Full Text] [Related]
13. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study. Tidy JA, Lyon R, Ellis K, Macdonald M, Palmer JE. BJOG; 2020 Sep 01; 127(10):1260-1267. PubMed ID: 32279427 [Abstract] [Full Text] [Related]
14. Screening of cervical neoplasia in HIV-infected women in India. Joshi S, Sankaranarayanan R, Muwonge R, Kulkarni V, Somanathan T, Divate U. AIDS; 2013 Feb 20; 27(4):607-15. PubMed ID: 23079814 [Abstract] [Full Text] [Related]